Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Apoptosis signaling proteins" is a nonspecific term encompassing various molecular components involved in the regulation and execution of programmed cell death. These proteins include the Bcl-2 family (pro- and anti-apoptotic regulators of mitochondrial membrane permeabilization), caspases (initiator and executioner proteases), death receptors (e.g., Fas and TNF receptors), IAP proteins (inhibitors of apoptosis), and other regulatory factors such as p53. The balance among these molecules determines a cell’s fate to survive or undergo orderly self-destruction. Dysregulation of apoptosis signaling proteins is implicated in many human diseases, most notably cancer, where too little apoptosis permits unchecked cell proliferation, and neurodegeneration, where excessive apoptosis leads to loss of vital cells[1][2][3][4][6][7].
Inhibition of anti-apoptotic Bcl-2 family members; Activation or mimicking of pro-apoptotic proteins; Caspase activation or inhibition; Death receptor activation (e.g., by agonists)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apoptosis signaling proteins.